StockNews.com cut shares of LeMaitre Vascular (NASDAQ:LMAT – Free Report) from a buy rating to a hold rating in a research report sent to investors on Friday. Other equities research analysts have also recently issued research reports about the company. JMP Securities initiated coverage on LeMaitre Vascular in a report on Monday, October 23rd. They […]
LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday. A number of other research analysts have also issued reports on the stock. Barrington Research raised their price objective on shares of LeMaitre Vascular from $62.00 to […]
Bank of New York Mellon Corp increased its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 0.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 244,181 shares of the medical instruments supplier’s stock after acquiring an additional 1,699 […]
LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) declared a quarterly dividend on Tuesday, October 24th, NASDAQ reports. Investors of record on Thursday, November 16th will be given a dividend of 0.14 per share by the medical instruments supplier on Thursday, November 30th. This represents a $0.56 dividend on an annualized basis and a yield […]
LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) announced its quarterly earnings results on Wednesday. The medical instruments supplier reported $0.33 EPS for the quarter, topping the consensus estimate of $0.31 by $0.02, Briefing.com reports. The company had revenue of $47.40 million during the quarter, compared to analyst estimates of $47.58 million. LeMaitre Vascular had a […]